BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29335631)

  • 41. HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment.
    Rimando J; Slade M; DiPersio JF; Westervelt P; Gao F; Liu C; Romee R
    Blood Adv; 2018 Dec; 2(24):3590-3601. PubMed ID: 30563883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients.
    Armstrong AE; Smyth E; Helenowski IB; Tse WT; Duerst RE; Schneiderman J; Kletzel M; Chaudhury S
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):26-32. PubMed ID: 27820121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Probability of high resolution full match for human leukocyte antigen loci in unrelated donors and recipients with low resolution match].
    Zhang W; Zhu FM; He YM; Tao SD; Wang W; He JJ; Lü HJ; Yan LX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1617-20. PubMed ID: 21176382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.
    Fernandez-Viña MA; Wang T; Lee SJ; Haagenson M; Aljurf M; Askar M; Battiwalla M; Baxter-Lowe LA; Gajewski J; Jakubowski AA; Marino S; Oudshoorn M; Marsh SG; Petersdorf EW; Schultz K; Turner EV; Waller EK; Woolfrey A; Umejiego J; Spellman SR; Setterholm M
    Blood; 2014 Feb; 123(8):1270-8. PubMed ID: 24408320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation.
    Wade JA; Hurley CK; Takemoto SK; Thompson J; Davies SM; Fuller TC; Rodey G; Confer DL; Noreen H; Haagenson M; Kan F; Klein J; Eapen M; Spellman S; Kollman C
    Blood; 2007 May; 109(9):4064-70. PubMed ID: 17202313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
    Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index.
    Bashey A; Zhang X; Jackson K; Brown S; Ridgeway M; Solh M; Morris LE; Holland HK; Solomon SR
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):125-33. PubMed ID: 26359881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
    Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO
    Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation.
    Kanda Y; Kanda J; Atsuta Y; Maeda Y; Ichinohe T; Ohashi K; Fukuda T; Miyamura K; Iida H; Mori T; Iwato K; Eto T; Kawa K; Morita S; Morishima Y
    Br J Haematol; 2013 May; 161(4):566-77. PubMed ID: 23452319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
    Chang YJ; Luznik L; Fuchs EJ; Huang XJ
    J Hematol Oncol; 2016 Apr; 9():35. PubMed ID: 27071449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
    Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic Disorders.
    Mallhi KK; Smith AR; DeFor TE; Lund TC; Orchard PJ; Miller WP
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):119-125. PubMed ID: 27989932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis.
    Tie R; Zhang T; Yang B; Fu H; Han B; Yu J; Tan Y; Huang H
    Oncotarget; 2017 Apr; 8(16):27645-27660. PubMed ID: 28206973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT.
    Fuji S; Kanda J; Kato S; Ikegame K; Morishima S; Miyamoto T; Hidaka M; Kubo K; Miyamura K; Ohashi K; Kobayashi H; Maesako Y; Adachi S; Ichinohe T; Atsuta Y; Kanda Y;
    Bone Marrow Transplant; 2014 Sep; 49(9):1187-92. PubMed ID: 25000457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on the outcome of unrelated bone marrow transplantation.
    Kanda Y; Kanda J; Atsuta Y; Fuji S; Maeda Y; Ichinohe T; Takanashi M; Ohashi K; Fukuda T; Miyamura K; Mori T; Sao H; Kobayashi N; Iwato K; Sawada A; Mori S;
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):526-35. PubMed ID: 24417871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis.
    Meybodi MA; Cao W; Luznik L; Bashey A; Zhang X; Romee R; Saber W; Hamadani M; Weisdorf DJ; Chu H; Rashidi A
    Blood Adv; 2019 Sep; 3(17):2581-2585. PubMed ID: 31484635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.
    Canaani J; Savani BN; Labopin M; Huang XJ; Ciceri F; Arcese W; Tischer J; Koc Y; Bruno B; Gülbas Z; Blaise D; Maertens J; Ehninger G; Mohty M; Nagler A
    Haematologica; 2017 Jun; 102(6):1066-1074. PubMed ID: 28255020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy.
    Morita-Fujita M; Shindo T; Iemura T; Arai Y; Kanda J; Okada K; Ueda Y; Yoshiyuki O; Anzai N; Mori T; Ishikawa T; Otsuka Y; Yonezawa A; Yuhi N; Imada K; Oba A; Itoh M; Okamoto Y; Kitano T; Ikeda T; Kotani S; Akasaka T; Yago K; Watanabe M; Nohgawa M; Tsuji M; Takeoka T; Yamamoto R; Arima N; Yoshinaga N; Hishizawa M; Yamashita K; Kondo T; Takaori-Kondo A;
    Transplant Cell Ther; 2023 Jun; 29(6):347.e1-347.e11. PubMed ID: 36889508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
    Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
    Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.